Estrella Immunopharma, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Estrella Immunopharma, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (7)
Estrella Immunopharma, Inc. made a loss over the last year. Estrella Immunopharma, Inc. owes $5.07 for every $1 it owns. Estrella Immunopharma, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossEstrella Immunopharma, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-4.25Estrella Immunopharma, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$32 MThe total market value of all of Estrella Immunopharma, Inc.'s shares at today's price (share price × number of shares), smaller than 79% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
NegativeEstrella Immunopharma, Inc.'s net worth is negative ($7 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
5.07×Estrella Immunopharma, Inc. owes $5.07 for every $1 it owns, so it owes more than it owns, higher than almost all Healthcare companies in United States.
Dividend yield
NoneEstrella Immunopharma, Inc. does not currently pay a dividend.
Profit growth
LossEstrella Immunopharma, Inc. made a loss in each of the last two years.
Questions
How much does Estrella Immunopharma, Inc. owe compared with what it owns?
Estrella Immunopharma, Inc. owes $5.07 for every $1 it owns, so it owes more than it owns, higher than almost all Healthcare companies in United States.
Does Estrella Immunopharma, Inc. pay a dividend?
No. Estrella Immunopharma, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.